Congress Materials – Psych Elevate 2025
2025 Psych Elevate | May 28-31 | Las Vegas, NV
Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From an Additional Randomized, Double-Blind, Phase 3 Trial
Willie R. Earley, Suresh Durgam, Susan G. Kozauer, Yifan Mo, Hassan Lakkis, Christopher Gallardo, Susan G. Kornstein, Maurizio Fava
Association of Antipsychotic Medication Nonadherence With All-Cause Mortality in Newly Treated Adults With Schizophrenia: A Retrospective Healthcare Claims Study
Christoph U. Correll, Brahim K. Bookhart, Carmela Benson, Zhiwen Liu, Zhongyun Zhao, Wenze Tang
Change in Clinician-Rated and Patient-Reported Depression Severity After Esketamine Nasal Spray as Monotherapy in Adult Patients With Treatment-Resistant Depression: A Post Hoc Analysis of Item Scores
Richard Shelton, Mai Himedan, Dong-Jing Fu, Ibrahim Turkoz, Amit Patel, Lisa Lim, Oliver Lopena
Earlier Use of Long-Acting Injectable Paliperidone Palmitate versus Oral Antipsychotics in Patients With Schizophrenia: A Post-hoc Analysis From PROSIPAL
Rebecca Roma, Nia Josiah, Monica Doring, Lisa Lim, Camilo Obando, Ibrahim Turkoz, James Simples Jr., Karen Johnston, Tyler Casey, Martha Sajatovic
Efficacy and Safety of Esketamine Nasal Spray as Monotherapy in Adult Patients With Treatment-Resistant Depression for up to 4 Months of Treatment: A Post Hoc Analysis
Andrew J Cutler, Dong-Jing Fu, Ibrahim Turkoz, Mai Himedan, Oliver Lopena, Lisa Lim, John S Verbanac
Longitudinal Real-World Study of the Patient Journey of a National Sample of Beneficiaries With Schizophrenia Dually Eligible for Medicare & Medicaid
Pengxiang Li, Zhi Geng, Carmela Benson, Charmi Patel, Jalpa A. Doshi
Long-Term Adjunctive Lumateperone Treatment in Major Depressive Disorder: Results From a Six-Month Open-Label Extension Study
Willie R. Earley, Suresh Durgam, Susan G. Kozauer, Changzheng Chen, Myaa Lightfoot, Andrew J. Cutler
Long-Term Efficacy and Safety of Esketamine Nasal Spray as Monotherapy: A Post Hoc Analysis of the SUSTAIN-3 Study
John Zajecka, Dong-Jing Fu, Ibrahim Turkoz, Patricia Cabrera, Oliver Lopena, Lisa Lim, Megan Kunka Fritz, Muhammad Ahmed
Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder and Anxious Distress
Suresh Durgam, Willie R. Earley, Susan G. Kozauer, Changzheng Chen, Betsy Yuan, Gary S. Sachs
Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder: Results From a Randomized, Double-blind, Phase 3 Trial
Suresh Durgam, Willie R. Earley, Susan G. Kozauer, Changzheng Chen, Hassan Lakkis, Christopher Gallardo, Roger S. McIntyre, Stephen Stahl
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.
Connect with us
Connect with us
Would you like to clear and leave your conversation? Message history will be lost.